This article explains, in educational terms, vascular access sheaths — how the technology works and where it fits. Device selection depends on lesion location, length, calcification, and clinical presentation, and is decided by the vascular specialist. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Peripheral Arterial Disease (PAD)
Peripheral arterial disease is the narrowing of arteries outside the heart — most often in the legs — due to atherosclerotic plaque, reducing blood flow to the limbs. Percutaneous transluminal angioplasty (PTA) uses a balloon to widen the artery, and drug-coated balloons add an antiproliferative agent to limit re-narrowing. Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting.
Vascular Access Sheaths
Introducer sheaths provide stable vascular access through which balloons, stents, and other devices are delivered. Sheath French size and length must match the intended devices and access site. INVAMED's Invaducer introducer sheath sets support the access step of peripheral interventions. Appropriate access selection helps reduce access-site complications.
Design and Technical Notes
INVAMED's PAD portfolio spans access, plaque modification, angioplasty, drug delivery, stenting, and embolic protection. INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals. Manufacturer figures reflect studied device performance, not guaranteed outcomes.
Key Considerations
- Access sheath sizing should match the planned devices to limit access-site complications.
- Lesion calcification is a major factor in choosing between plain angioplasty, atherectomy, drug delivery, and stenting.
- INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals.
Frequently Asked Questions
Is a stent always needed in PAD?
No. Many lesions are treated with angioplasty or drug-coated balloons alone; a stent is added when the vessel recoils or dissects.
What atherectomy device does INVAMED make?
INVAMED's TemREN system is positioned for peripheral atherectomy and plaque modification, often used with the Guardian embolic protection device.
Why use embolic protection?
It captures plaque or clot fragments dislodged during treatment so they do not travel downstream; it is often paired with atherectomy.
About INVAMED
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Clinical and Technical Context
INVAMED's Guardian protection device is designed for this distal-capture role. Atherectomy is often paired with embolic protection to capture dislodged debris. Drug dose and balloon sizing follow the device specifications and lesion characteristics. Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting. Embolic protection is often paired with atherectomy to capture dislodged debris. INVAMED's Invaducer introducer sheath sets support the access step of peripheral interventions. Percutaneous transluminal angioplasty (PTA) uses a balloon to widen the artery, and drug-coated balloons add an antiproliferative agent to limit re-narrowing. Covered stent grafts can be used to exclude certain lesions or manage complications. Device selection depends on lesion location, length, calcification, and clinical presentation, and is decided by the vascular specialist. INVAMED's TemREN atherectomy system is positioned for peripheral plaque modification. INVAMED's Atlas peripheral stent graft addresses covered-stent applications in the PAD portfolio. INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals. Manufacturer figures reflect studied device performance, not guaranteed outcomes. Use is guided by lesion morphology and clinician preference. Peripheral arterial disease is the narrowing of arteries outside the heart — most often in the legs — due to atherosclerotic plaque, reducing blood flow to the limbs. Femoropopliteal segments favor flexible self-expanding devices because of repeated flexion. Lesion calcification is a major factor in choosing between plain angioplasty, atherectomy, drug delivery, and stenting. INVAMED's PTA balloon range is designed to cover common peripheral vessel sizes. Appropriate access selection helps reduce access-site complications. INVAMED's Extender paclitaxel drug-coated balloon is positioned for this drug-delivery role in peripheral vessels.
Related on INVAMED
- Peripheral Arterial Disease (PAD) — product category
- Drug-Coated Balloons (DCB): Technology, Uses and Considerations
- Drug-coated balloon or Drug-eluting stent? A Technical Comparison
- Invaducer Intraducer (Introducer Sheath Sets): What Clinicians and Buyers Should Know
Important Disclaimer
This content is educational and technical in nature and must not be interpreted as medical advice or as a promise of any clinical outcome. Individual results depend on many factors and can only be evaluated by a treating physician. Figures attributed to INVAMED reflect manufacturer or published data and are not a guarantee of results. All INVAMED devices are to be used by trained clinicians per the approved IFU, and availability is subject to local regulatory status.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.